View in EDS

Efficacy of adjuvant nivolumab in patients with upper tract predominant urothelial carcinoma: A single-center real-world study.

Saved in:

Bibliographic Details
Title:	Efficacy of adjuvant nivolumab in patients with upper tract predominant urothelial carcinoma: A single-center real-world study.
Authors:	Chen YC; Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Beitou District, Taipei, Taiwan., Lai JI; Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Beitou District, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming Chiao Tung University, Beitou District, Taipei, Taiwan., Chang YH; Division of General Urology, Department of Urology, Taipei Veterans General Hospital, Beitou District, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming Chiao Tung University, Beitou District, Taipei, Taiwan., Chung HJ; Division of General Urology, Department of Urology, Taipei Veterans General Hospital, Beitou District, Taipei, Taiwan., Lin TP; Division of General Urology, Department of Urology, Taipei Veterans General Hospital, Beitou District, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming Chiao Tung University, Beitou District, Taipei, Taiwan., Huang YH; Division of General Urology, Department of Urology, Taipei Veterans General Hospital, Beitou District, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming Chiao Tung University, Beitou District, Taipei, Taiwan., Wei TC; Division of General Urology, Department of Urology, Taipei Veterans General Hospital, Beitou District, Taipei, Taiwan., Chen MH; Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Beitou District, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming Chiao Tung University, Beitou District, Taipei, Taiwan., Yen CC; Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Beitou District, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming Chiao Tung University, Beitou District, Taipei, Taiwan., Chang PM; Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Beitou District, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming Chiao Tung University, Beitou District, Taipei, Taiwan; Institute of Biopharmaceutical Sciences, National Yang-Ming Chiao Tung University, Beitou District, Taipei, Taiwan. Electronic address: ptchang@vghtpe.gov.tw.
Source:	Urologic oncology [Urol Oncol] 2025 Dec; Vol. 43 (12), pp. 697.e11-697.e18. Date of Electronic Publication: 2025 Aug 09.
Publication Type:	Journal Article
Journal Info:	Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1873-2496
DOI:	10.1016/j.urolonc.2025.07.014